본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

eEnzyme

[eEnzyme] SARS-CoV-2 Pseudoviral Particles, the JN.1.18 Variant

Cat-No. SCV2-PsV-JN1.18

eEnzyme는 다양한 생물에서 단백질 발현을 최적화하는 코돈 최적화 서비스를 제공하는 미국의 Biological 기업입니다.




제품 설명


SARS-CoV-2 Pseudoviral Particles, the JN.1.18 Variant




제품 번호


SCV2-PsV-JN1.18




제품 특징


SARS-CoV-2 Pseudoviral Particles, replication-deficient MLV pseudotyped with the SARS-CoV-2 spike protein (the newer variant, JN.1.18).


SCV2-PsV-JN1.18

Name

SARS-CoV-2 Pseudoviral Particles, the JN.1.18 Variant

Description

The SARS-CoV-2 Pseudoviral Particles are replication-deficient Maloneymurine leukemia virus (MLV or MuLV) pseudotyped with the SARS-CoV-2 spike protein carrying the Omircon JN.1.18 variant genotype (GISAID Accession # EPI_ISL_18827981).
MLV-based virus system is a better choice than HIV-based lentivirus system for making pseudoviral particles in regards of lab safety and product quality. Gag-Pol is the only component from MLV.

Applications

Our Pseudovirus Particles generate robust chemiluminescent signals in cell assays when coupled with our firefly luciferase assay kit (Catalog # CA-L165), useful for 1) screening potential inhibitors to block SARS-CoV-2 entry and viral protein; 2) measuring the activity of and screening for neutralizing antibody against SARS-CoV-2. 

Size

5 ml, for one multi-well plate

Storage

-70oC. Shipped on dry ice.

Note

1. Amenable to HTS format (96-well, 384-well and 1536-well format). 
2. HEK293-hACE2 stable cells are available seperately (Cat..#  
CL-hACE2-001CL-hACE2-002)

For Downloading

==>> DATA SHEET       ==>> SAFETY DATA SHEET




eEnzyme - Official Distributor in South Korea "Morebio" 한국 공식 대리점 "모아바이오"